Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer

European Journal of Cancer(2021)

引用 26|浏览31
暂无评分
摘要
•Current biomarkers for PD-1 blockade are suboptimal and require invasive procedures.•Reduction of PD-1+ cells in CD8+ T lymphocytes predicts favourable treatment outcomes.•Suppressive function of circulating PD-1+CD8+ T lymphocytes was uncovered.
更多
查看译文
关键词
Anti-programmed cell death-1 treatment,Non-small-cell lung cancer,CD8+ T lymphocytes,Biomarker
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要